Omega Healthcare Investors OHI Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.24B+3.9% | $1.19B+3.5% | $1.15B+3.2% | $1.11B+2.7% | $1.08B+3.2% | ||
| $98.1M-5.8% | $104.14M+1.9% | $102.24M+2.0% | $100.22M+1.7% | $98.53M+12.0% | ||
| $679.85M-1.2% | $688.02M+2.0% | $674.27M+0.3% | $672.19M+3.4% | $650.13M+0.2% | ||
| —— | —— | —— | —— | —— | ||
| $212.51M-1.2% | $215.04M-1.6% | $218.53M+1.6% | $215.11M-0.5% | $216.18M-2.5% | ||
| $113.33M-7.4% | $122.36M+27.6% | $95.86M+94.3% | $49.34M+71.5% | $28.77M+57.7% | ||
| $669.76M+7.3% | $624.43M+9.2% | $571.78M+16.3% | $491.79M+6.1% | $463.51M+10.2% | ||
| $16.24M+10.1% | $14.75M-5.5% | $15.6M+8.1% | $14.44M+21.4% | $11.89M+9.5% | ||
| $632.2M+7.1% | $590.19M+9.6% | $538.69M+14.4% | $470.73M+5.1% | $448M+10.3% | ||
| 51.1%+1.5pp | 49.6%+2.8pp | 46.8%+4.6pp | 42.2%+0.9pp | 41.3%+2.6pp | ||
| $2.07+7.3% | $1.93+7.8% | $1.79+10.5% | $1.62+0.6% | $1.61+3.9% | ||
| $1.21B+4.0% | $1.16B+4.8% | $1.11B+8.6% | $1.02B+3.4% | $989.65M+4.5% | ||
| 98%+0.2pp | 97.9%+1.2pp | 96.6%+4.8pp | 91.8%+0.6pp | 91.2%+1.1pp | ||
| $882.27M+5.1% | $839.47M+6.2% | $790.32M+11.8% | $706.89M+4.0% | $679.69M+5.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Omega Healthcare Investors's revenue?
- Omega Healthcare Investors (OHI) generated $1.2B in revenue over the trailing twelve months, up 14.0% year over year.
- Is Omega Healthcare Investors profitable?
- Omega Healthcare Investors reported $632.2M in net income over the trailing twelve months, a 51.1% net margin.
- What is Omega Healthcare Investors's earnings per share?
- Omega Healthcare Investors's diluted EPS over the trailing twelve months is $2.07.
- Where does Omega Healthcare Investors's income statement data come from?
- Every line is extracted from Omega Healthcare Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
